Sumitomo Riko is implementing Ansys, part of Synopsys, Inc. (NASDAQ: SNPS) AI technology with the goal of accelerating ...
Gilead Sciences has bolstered its position in the development of next-generation cancer cell therapies with a deal to absorb Tmunity Therapeutics into its Kite unit. Kite has agreed to acquire all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback